Centene (NYSE:CNC) Posts Quarterly Earnings Results, Beats Estimates By $1.42 EPS

Centene (NYSE:CNCGet Free Report) released its quarterly earnings results on Monday. The company reported $2.51 earnings per share for the quarter, topping the consensus estimate of $1.09 by $1.42, FiscalAI reports. The company had revenue of $53.58 billion during the quarter, compared to the consensus estimate of $47.64 billion. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.Centene’s revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the business posted ($0.16) earnings per share.

Centene Stock Performance

CNC stock traded down $0.75 during mid-day trading on Wednesday, reaching $63.16. The company had a trading volume of 612,513 shares, compared to its average volume of 6,060,450. The stock’s 50-day simple moving average is $63.67 and its two-hundred day simple moving average is $49.98. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $31.19 billion, a P/E ratio of -4.82, a P/E/G ratio of 0.50 and a beta of 1.07. Centene has a one year low of $25.08 and a one year high of $69.36.

Key Stories Impacting Centene

Here are the key news stories impacting Centene this week:

  • Positive Sentiment: Strong Q2 results: Centene reported $53.58 billion in revenue, up 9.9% year over year, while adjusted diluted EPS of $2.51 substantially exceeded the $1.09 consensus estimate. GAAP diluted EPS was $2.19, compared with a loss of $0.16 a year earlier. Centene Corporation Reports Second Quarter 2026 Results
  • Positive Sentiment: Higher full-year guidance: Management raised 2026 adjusted EPS guidance to above $4.80 and lifted revenue guidance to $193.5 billion-$197.5 billion, above analysts’ expectations. The company attributed the improvement to better cost management and stronger performance across Medicare, Medicaid and Marketplace businesses. Centene Raises Annual Profit Forecast on Better Cost Control
  • Positive Sentiment: Improved profitability metrics: The health benefits ratio fell to 89.6% from 93.0% a year earlier, indicating lower medical costs relative to premiums. Commercial HBR improved to 79.2%, while Medicare also showed favorable performance. Centene Back on Track
  • Neutral Sentiment: Analyst view remains cautious: Robert W. Baird raised its price target from $46 to $66 but maintained a “neutral” rating. The new target implies only modest additional upside, suggesting the earnings recovery is largely reflected in the share price.
  • Neutral Sentiment: Board change: Director Kenneth A. Burdick retired from Centene’s board, effective July 28. The company did not indicate that the change would alter its strategy. Centene Announces Board of Directors Changes
  • Negative Sentiment: Membership remains a risk: Total at-risk membership declined to 25.885 million, with Medicaid membership softness highlighted by analysts. Continued enrollment losses or higher medical costs could weaken the improved margin trend and pressure future earnings.

Institutional Investors Weigh In On Centene

Several hedge funds have recently modified their holdings of the stock. Caption Management LLC raised its stake in Centene by 107.8% during the 3rd quarter. Caption Management LLC now owns 3,500 shares of the company’s stock valued at $125,000 after purchasing an additional 48,500 shares during the period. Smartleaf Asset Management LLC grew its position in Centene by 23.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,868 shares of the company’s stock valued at $118,000 after purchasing an additional 551 shares in the last quarter. Brown Brothers Harriman & Co. raised its holdings in shares of Centene by 123.2% during the third quarter. Brown Brothers Harriman & Co. now owns 3,238 shares of the company’s stock worth $116,000 after acquiring an additional 1,787 shares in the last quarter. Geneos Wealth Management Inc. grew its position in Centene by 29.8% in the second quarter. Geneos Wealth Management Inc. now owns 1,897 shares of the company’s stock worth $103,000 after acquiring an additional 435 shares in the last quarter. Finally, Larson Financial Group LLC grew its holdings in Centene by 65.5% during the third quarter. Larson Financial Group LLC now owns 2,796 shares of the company’s stock valued at $100,000 after purchasing an additional 1,107 shares during the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CNC has been the subject of several recent analyst reports. Truist Financial raised their target price on Centene from $71.00 to $78.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Wall Street Zen upgraded shares of Centene from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 18th. TD Cowen reiterated a “hold” rating and set a $65.00 price objective (up from $47.00) on shares of Centene in a research note on Tuesday, July 14th. Royal Bank Of Canada boosted their target price on shares of Centene from $70.00 to $71.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Finally, The Goldman Sachs Group reaffirmed a “sell” rating and set a $40.00 price target on shares of Centene in a research report on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $66.50.

View Our Latest Analysis on Centene

About Centene

(Get Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Recommended Stories

Earnings History for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.